Brinson, R.
, Marino, J.
, Delaglio, F.
, Arbogast, L.
, Evans, R.
, Kearsley, A.
, Aubin, Y.
, Pierens, G.
, Jia, X.
, Keizer, D.
, Stahle, J.
, Widmalm, G.
, Lawrence, C.
, Reardon, P.
, Cort, J.
, Kato, K.
, Parnham, S.
, Blomgren, A.
, Rundlof, T.
, Chen, K.
, Keire, D.
, Suter-Stahel, T.
, Wider, G.
, Baldisseri, D.
, Wu, J.
, Wikstrom, M.
and Mobli, M.
(2019),
Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics, mAbs, [online], https://doi.org/10.1080/19420862.201
(Accessed August 13, 2024)